1,143 research outputs found

    Cosmic Dust Collection Facility: Scientific objectives and programmatic relations

    Get PDF
    The science objectives are summarized for the Cosmic Dust Collection Facility (CDCF) on Space Station Freedom and these objectives are related to ongoing science programs and mission planning within NASA. The purpose is to illustrate the potential of the CDCF project within the broad context of early solar system sciences that emphasize the study of primitive objects in state-of-the-art analytical and experimental laboratories on Earth. Current knowledge about the sources of cosmic dust and their associated orbital dynamics is examined, and the results are reviewed of modern microanalytical investigations of extraterrestrial dust particles collected on Earth. Major areas of scientific inquiry and uncertainty are identified and it is shown how CDCF will contribute to their solution. General facility and instrument concepts that need to be pursued are introduced, and the major development tasks that are needed to attain the scientific objectives of the CDCF project are identified

    Knowledge Brokering and Organizational Innovation: Founder Imprinting Effects

    Get PDF
    We empirically examine the innovation consequences of organizational knowledge brokering, the ability to effectively apply knowledge from one technical domain to innovate in another. We investigate how organizational innovation outcomes vary by founders’ initial mode of venture ideation. We then compare how firms established with knowledge-brokering-based ideation differ in their methods of sustaining ongoing knowledge-brokering capacity compared with firms not established in such a manner. We do so by tracking all the start-up biotechnology firms founded to commercialize the then-emergent recombinant DNA technology (the sample of initial knowledge brokers) together with a contemporaneously founded sample of biotechnology firms that did not license the DNA technology (the sample of initial nonbrokers). Our results suggest that (a) ongoing knowledge brokering has an inverted U-shaped relationship with innovative performance in general; (b) initial knowledge brokers have a positive imprinting effect on their organizations’ search patterns over time, resulting in superior performance relative to nonbrokers; and (c) initial nonbrokers rely more on external channels of sourcing knowledge, such as hiring technical staff, relative to initial brokers, reinforcing the imprinting interpretation. The described imprinting mechanism differs from extant mechanisms such as partner affiliation- and trigger-based mechanisms in explaining entrepreneurial performance differentials

    Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health

    Get PDF
    Background: The emergence of carbapenemase producing bacteria, especially New Delhi metallo-β-lactamase (NDM-1) and its variants, worldwide, has raised amajor public health concern. NDM-1 hydrolyzes a wide range of β-lactam antibiotics, including carbapenems, which are the last resort of antibiotics for the treatment of infections caused by resistant strain of bacteria. Main body: In this review, we have discussed blaNDM-1variants, its genetic analysis including type of specific mutation, origin of country and spread among several type of bacterial species. Wide members of enterobacteriaceae, most commonly Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and gram-negative non-fermenters Pseudomonas spp. and Acinetobacter baumannii were found to carry these markers. Moreover, at least seventeen variants of blaNDM-type gene differing into one or two residues of amino acids at distinct positions have been reported so far among different species of bacteria from different countries. The genetic and structural studies of these variants are important to understand the mechanism of antibiotic hydrolysis as well as to design new molecules with inhibitory activity against antibiotics. Conclusion: This review provides a comprehensive view of structural differences among NDM-1 variants, which are a driving force behind their spread across the globe

    Posttranslational Modifications and the Immunogenicity of Biotherapeutics

    Get PDF
    Whilst the amino acid sequence of a protein is determined by its gene sequence, the final structure and function are determined by posttranslational modifications (PTMs), including quality control (QC) in the endoplasmic reticulum (ER) and during passage through the Golgi apparatus. These processes are species and cell specific and challenge the biopharmaceutical industry when developing a production platform for the generation of recombinant biologic therapeutics. Proteins and glycoproteins are also subject to chemical modifications (CMs) both in vivo and in vitro. The individual is naturally tolerant to molecular forms of self-molecules but nonself variants can provoke an immune response with the generation of anti-drug antibodies (ADA); aggregated forms can exhibit enhanced immunogenicity and QC procedures are developed to avoid or remove them. Monoclonal antibody therapeutics (mAbs) are a special case because their purpose is to bind the target, with the formation of immune complexes (ICs), a particular form of aggregate. Such ICs may be removed by phagocytic cells that have antigen presenting capacity. These considerations may frustrate the possibility of ameliorating the immunogenicity of mAbs by rigorous exclusion of aggregates from drug product. Alternate strategies for inducing immunosuppression or tolerance are discussed

    Examination of the immunoglobulin repertoire before and after Anthrax Vaccine Adsorbed immunization

    Full text link
    Anthrax Vaccine Adsorbed (AVA) immunization protects against anthrax disease by eliciting a neutralizing antibody response. However, antigen-specific antibody concentrations are not observed in high quantities until three immunizations have been administered over six months. Even then, humoral responses to AVA do not provide long-term immunity without an annual booster. We followed six healthy volunteers over the five-dose, 18-month AVA schedule to characterize the genetics of the immunoglobulin repertoire during the vaccination series. Two tiers of data were collected: 1) Immunoglobulin variable region genes (IgVRG) from bulk sorted naĂŻve, memory and plasmablast (PB) B cells and 2) single cell sorted and sequenced IgVRG from plasmablasts. Samples were collected prior to and one and two weeks following each immunization. Our initial analyses indicated that technical error, the variation introduced by biological sampling and standard sample preparation, resulted in skewed output, and we developed a model to better estimate quantitative values from Ig-seq. We also utilized unique molecular identifiers to correct for nucleotide errors and PCR over-amplification. Our analysis of IgVRG following AVA administration reveals that the population of peripheral PBs following primary immunization is not distinguishable from the pre-immune peripheral PB repertoire. These PBs have more somatic mutations than expected for newly activated and differentiated naĂŻve B cells, and are unlikely to be vaccine-elicited. In contrast, PBs observed following the 2nd dose have low mutation frequencies that increase upon subsequent vaccination. These clones are more persistent than clones first observed following any other immunization, but still make up a very small proportion of the overall repertoire. At no time is the clonal repertoire consistently dominated by a few clones, and the total and plasmablast repertoires are highly transient, even after the elicitation of vaccine-specific antibodies. AVA immunization thus results in a polyclonal B cell response which is not dominated by one or a few highly specific, strongly-elicited clones. We conclude that primary immunization by AVA is not sufficiently immunogenic to elicit vaccine-responsive, class-switched PBs to the periphery, nor is complete AVA immunization able to sustain proliferation of individual clones, providing insight into why AVA may require regular boosts
    • …
    corecore